LifeCare Partners

LifeCare Partners is a private equity and venture capital firm based in Basel, Switzerland, specializing in providing financing to private and public companies within the life science and healthcare industries. The firm's investment focus spans a broad spectrum, including medical technology, diagnostics, biopharmaceuticals, generics, food & nutrition, industrial biotechnology, biomaterials, e-health, and bioenergy sectors. They also demonstrate an interest in related areas such as software services and big data solutions within the healthcare landscape.

The investment firm, LifeCare Partners, was founded in 2014, although the legal entity "LifeCare Partners GmbH" has a registration history dating back to 2007. Gerhard Ries is identified as a key managing partner within the firm. The establishment of LifeCare Partners aimed to offer crucial financing and strategic guidance to innovative enterprises poised for growth and development in the dynamic life science and healthcare sectors.

LifeCare Partners has built a notable portfolio of investments, including companies such as KUPANDO, B-rayZ, NeoPredics, Immunic, Kuros Biosciences, and Leon-nanodrugs. These investments reflect the firm's engagement across various funding stages, from early-stage venture rounds like Series A and Series B to later-stage and post-IPO financing. The firm typically participates in deals ranging from $10 million to $50 million, with an average round investment of approximately $6.98 million.

The team at LifeCare Partners, based in Basel, Switzerland, possesses significant expertise in the life science and healthcare investment landscape. They have a proven track record of successfully investing in numerous companies, many of which have achieved successful exits through public listings or acquisitions by leading industry players. The firm leverages this deep industry knowledge and experience to identify promising ventures and support their development and innovation.